Evidence map›Paper›PMID 37664757›Full record

ArticleHeliyon2023

Deep fusion of multi-modal features for brain tumor image segmentation.

Guying Zhang, Jia Zhou, Guanghua He, Hancan Zhu

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guying ZhangSchool of Mathematics, Physics and Information, Shaoxing University, Shaoxing, Zhejiang, 312000, China.
Jia ZhouCancer Center, Gamma Knife Treatment Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
Guanghua HeSchool of Mathematics, Physics and Information, Shaoxing University, Shaoxing, Zhejiang, 312000, China.
Hancan ZhuSchool of Mathematics, Physics and Information, Shaoxing University, Shaoxing, Zhejiang, 312000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate segmentation of pathological regions in brain magnetic resonance images (MRI) is essential for the diagnosis and treatment of brain tumors. Multi-modality MRIs, which offer diverse feature information, are commonly utilized in brain tumor image segmentation. Deep neural networks have become prevalent in this field; however, many approaches simply concatenate different modalities and input them directly into the neural network for segmentation, disregarding the unique characteristics and complementarity of each modality. In this study, we propose a brain tumor image segmentation method that leverages deep residual learning with multi-modality image feature fusion. Our approach involves extracting and fusing distinct and complementary features from various modalities, fully exploiting the multi-modality information within a deep convolutional neural network to enhance the performance of brain tumor image segmentation. We evaluate the effectiveness of our proposed method using the BraTS2021 dataset and demonstrate that deep residual learning with multi-modality image feature fusion significantly improves segmentation accuracy. Our method achieves competitive segmentation results, with Dice values of 83.3, 89.07, and 91.44 for enhanced tumor, tumor core, and whole tumor, respectively. These findings highlight the potential of our method in improving brain tumor diagnosis and treatment through accurate segmentation of pathological regions in brain MRIs.

Indexed as

Brain tumor segmentationDeep convolutional networkDeep residual learningMulti-modality fusion

Identifiers

PMID37664757
PMCPMC10468380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.